Biopharmaceuticals
Oncology
Regulatory
FDA
News Release - February 14, 2013
Verastem Files for Orphan Disease Status for VS-6063 in Mesothelioma
Source: Verastem
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.